HIGHLIGHTS
- who: Christian Rausch and colleagues from the Department of Medical Oncology, Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland have published the article: Combining BeEAM with Brentuximab Vedotin for High-Dose Therapy in CD30 Positive Lymphomas before Autologous Transplantationu2014A Phase I Study, in the Journal: (JOURNAL) of 24/08/2017
- what: Again, a relationship to the study drug (BV) administration was considered unlikely for these infectious complications. This study investigated the use of BV in combination with HDCT before ASCT in the This study investigated the use of BV in combination with HDCT before . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.